期刊文献+

雌二醇对MKP-1的调控与围绝经期抑郁症的相关性研究 被引量:2

Regulation of estrogen level on MKP-1 and its relationship with perimenopausal depression
下载PDF
导出
摘要 目的探讨围绝经期女性雌二醇水平对丝裂原活化蛋白激酶磷酸酶-1(MKP-1)代谢通路的调控与高发的抑郁症的关系。方法根据汉密尔顿抑郁量表(HAMD-17)评分及ICD-10"抑郁发作"的诊断标准入选196例研究对象并采集外周血标本。采用电化学发光法检测雌二醇(E_2),ELISA双抗体夹心法检测MKP-1蛋白水平,比较各组之间的差异及其相关性。结果围绝经期抑郁症组与其他三组比较,E_2水平降低(Z值分别为-1.887、-6.561、-7.563,均P<0.05),MKP-1水平升高(P<0.05),HAMD评分和E_2分级呈负相关关系(R=-0.227,P=0.033);HAMD与MKP-1显示正相关(R=0.287,P=0.000);E_2分级与MKP-1显示负相关(R=-0.264,P=0.000)。结论围绝经期雌激素水平的降低引发MKP-1水平升高,可能导致抑郁症的高发。 [ Abatract] Objective To study the regulation of estrogen level on mitogen-activated protein kinase phosphatase-1 ( MKP-1 ) and its relationship with high incidence of depression among perimenopausal women.Methods In accordance with the diagnostic criteria of depressive episode of ICD and Hamilton Depression ( HAMD-17 ) rating scale, 196 women were recruited and their blood samples were collected.Peripheral blood estradiol ( E2 ) was detected by electrochemiluminescence assay, and ELISA was used to detect MKP-1 protein level.The difference and relevance among different groups were compared.Results Compared to the other three groups , E2 level in the perimenopausal depression group decreased(Z value was -1.887, -6.561 and -7.563, respectively, all P〈0.05),but MKP-1 level increased (P〈0.05).HAMD scores were negatively correlated with E2 grading(R=-0.227,P=0.033)but positively correlated with MKP-1 levels(R=0.287,P=0.000).E2 levels were negatively correlated with MKP-1 levels (R =-0.264,P=0.000).Conclusion The decrease of estrogen level of perimenopausal women causes the increase of MKP-1 level, which probably leads to the high incidence of perimenopausal depression.
出处 《中国妇幼健康研究》 2015年第5期931-933,共3页 Chinese Journal of Woman and Child Health Research
关键词 雌激素:丝裂原活化蛋白激酶磷酸酶-1 围绝经期 抑郁症 estrogen MKP-1 perimenopausal period depression
  • 相关文献

参考文献13

  • 1Freeman E W. Associations of depression with the transition to menopause[J]. Menopause,2010,17 (4) :823-827.
  • 2Manetsch M, Che W, Seidel P, et al. MKP-I:a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells[J]. Cell Signal,2012,24(4) :907-913.
  • 3Duric V, Banasr M, Licznerski P, et al. A negative regulator of MAP kinase causes depressive behavior [J]. Nat Med, 2010, 16 ( 11 ) : 1328-1332.
  • 4de Dios C H, Rom(m E, Monge R A, et al. The role of MAPK signal transduction pathways in the response to oxidative stress in the fungal pathogen Candida albicans: implications in virulence [J]. Curr Protein Pept Sci, 2010,11 (8) :693-703.
  • 5Wancket LM, Frazier W J, Liu Y. Mitogen-activated protein kinase phosphatase (MKP)-I in immunology, physiology, and disease [J]. Life Sci,2012,90(7-8) :237-248.
  • 6Comalada M, Lloberas J, Celada A. MKP-1 : a critical phosphatase in the biology of macrophages controlling the switch between proliferation and activation [J]. Eur J Immunol, 2012,42 ( 8 ) : 1938- 1948.
  • 7Ristiansen M, Hughes R, Patel P, et al. Mkpl is a c-Jun target gene that antagonizes JNK-dependent apoptosis in sympathetic neurons [J]. J Neurosci,2010,30 (32) : 10820-10832.
  • 8Aguirre C C, Baudry M. Progesterone reverses 17beta-estradiol- mediated neuroprotection and BDNF induction in cultured hippocampal slices [J]. Eur J Neurosci, 2009,29 ( 3 ) :447-454.
  • 9Shi Y, You J, Yuan Y, et al. Plasma BDNF and tPA are associated with late-onset geriatric depression [J]. Psychiatry Clin Neurosci, 2010,64(3) :249-254.
  • 10Jeanneteau F, Deinhardt K. brain: The role of MKP-1 [J] . Fine-tuning MAPK signaling in the Commun Integr Biol,2011,4 ( 3 ) :281-283.

二级参考文献51

  • 1Lin Y, Sarfraz Y, Jensen A,et al. Participation of brainstem monoaminergic nuclei in behavioral depression. Pharmacol Biochem Be, 2011, 100 : 330 -339.
  • 2Herken H, Gurel A, Selek S, et al. Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res, 2007, 38 : 247 - 252.
  • 3Romano-Torres M, Fernandez-Guasti A. Estradiol valerate e?licits antidepressant -like effects in middle-aged female rats under chronic mild stress. Behav Pharmacol, 2010, 21 : 104 -111.
  • 4Karakaya S, Kipp M, Beyer C. Oestrogen regulates the ex?pression and function of dopamine transporters in astrocytes of the nigrostriatal system. J Neuroendocrinol, 2007, 19 : 682 -690.
  • 5Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pa?thology in depression. CNS Neurol Disord Drug Targets, 2007,6: 219 -233.
  • 6Crespi F. Influence of neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: An in vi?vo electrochemical study. Brain Res, 2011, 1407 : 27- 37.
  • 7Morales-Medina JC, Dumont Y, Benoit CE, et al. Role of neuropeptide Y Y -1 and Y -2 receptors on behavioral despair in a rat model of depression with co-morbid anxiety. Neurop?harmacology, 2012, 62: 200 - 208.
  • 8Mickey BJ, Zhou ZF, Heitzeg MM, et al. Emotion process?ing, major depression, and functional genetic variation of neuropeptide Y. Arch Gen Psychiat , 2011, 68: 158 -166.
  • 9Dworkin S, Heath JK, delong-Curtain TA,et al. CREB ac?tivity modulates neural cell proliferation, midbrain-hind?brain organization and patterning in zebrafish. Dev Bioi, 2007, 307: 127 - 141.
  • 10Harrison NA, Brydon L, Walker C, et al. Neural origins of human sickness in interoceptive responses to inflammation. Bioi Psychiatry, 2009, 66: 415 - 422.

共引文献68

同被引文献19

引证文献2

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部